CNH e xpands c onnectivity s olutions with SpaceX’s Starlink . Basildon, May 15, 2025. CNH (NYSE: CNH) announces that it has signed an agreement with Starlink, a subsidiary of S ...

The first AI and machine learning based hydropower plant put to use by PVO and Oulu University. Klinkmann Oy supported with the latest Rockwell Automation AI technology - more effective turbine ...

Inderes' revenue grew by 8 percent in April 2025 to MEUR 2.4 (2.2). The revenue growth was mainly based on strong growth in AGM licenses sales in the Software business. This was positively affected by ...

Solar Foods and KelpEat, a pioneering Italian food innovator dedicated to revolutionising sustainable nutrition, have signed a Supply Agreement of up to EUR 0.5 million. By developing innovative and ...

May 15, 2025 at 14:15:00 EEST. Kamux Corporation has received on May 15, 2025 the following notification pursuant to Chapter 9, Sectio ...

Meriaura Group’s subsidiary Rasol Oy has annouced the launch of ’Sunplussa’, a smart system that integrates local energy production, storage, and consumption control for homes and buildings. The ...

Alira Health, a global healthcare consulting and research organization, today released its fifth annual report on the state of the contract development and manufacturing organization (CDMO) market in ...

Skyharbour Resources Ltd. (TSX-V: SYH) (OTCQX: SYHBF) (Frankfurt: SC1P) (“Skyharbour” or the “Company”), is pleased to anno ...

Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing, and care delivered in the home, has been named the Official Sleep Partner of the Qatar Airways British ...

Honka launches a new non-settling CLT log, Honka Fusion+, that facilitates even more ambitious and ecological massive wood construction. The new solid construction and streamlined design make ...

VCI Global Limited (NASDAQ: VCIG) (“VCI Global”) today announced that its fintech subsidiary, Credilab Sdn Bhd (“Credilab” or the “Company”) has secured a conditional approval for a digital ...

Fabhalta APPULSE-PNH full results build on Phase III program, reporting new data from expanded PNH population in adults switching from anti-C5 Ianalumab Phase II data in immune thrombocytopenia and ...